Jpmorgan Chase & Co »

Aptevo Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Aptevo Therapeutics (APVO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $7 43 0.19
2024-06-30 $12 43 0.30
2024-03-31 $202 43 4.70